Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Pregnancy and Childbirth
Published in: BMC Pregnancy and Childbirth 1/2019

Open Access 01-12-2019 | Neonatal Hypoglycemia | Research article

Change in prevalence of gestational diabetes and obstetric complications when applying IADPSG screening criteria in a Belgian French speaking University Hospital. A retrospective cohort study

Authors: Elena Costa, Christine Kirckpartick, Colette Gerday, Aricia De Kempeneer, Sara Derisbourg, An Vercoutere, Sophie Haumont, Axelle Pintiaux, Caroline Daelemans

Published in: BMC Pregnancy and Childbirth | Issue 1/2019

Login to get access

Abstract

Background

In April 2012 our institution chose to switch from a two- step criteria for Gestational Diabetes Mellitus (GDM) screening, to the International Association of Diabetes in Pregnancy Study Group (IADSPG) criteria. This shift led to an increased prevalence of GDM in our pregnant population. We designed a study in order to estimate the magnitude of the increase in GDM prevalence before and after the switch in screening strategy. As a secondary objective we wanted to evaluate if there was a significant difference between the two periods in the percentage of maternal and neonatal complications such as gestational hypertensive disorders (GHD), primary cesarean section (pCS), preterm birth, large for gestational age (LGA) newborns, macrosomia, shoulder dystocia, 5′ Apgar score less than to 7 at birth, neonatal intensive care unit (NICU) transfer and neonatal hypoglycemia.

Methods

We selected retrospectively 3496 patients who delivered between January 2009 and December 2011 who were screened with the two-step criteria (group A), and compared them to 2555 patients who delivered between January 2013 and December 2014 and who were screened with IADPSG criteria (Group B). We checked patients’ electronic files to establish GDM status, baseline characteristics (age, body mass index, nationality, parity) and the presence of maternal and neonatal complications.

Results

GDM prevalence increased significantly from group A (3.4%; 95%CI 2.8–4.06%) to group B (16.28%; 95%CI 14.8 -17.7%). In group B there were significantly more non-Belgian and primiparous patients. There was no statistically significant difference in maternal and neonatal complications between the two groups, even after adjustment for nationality and parity.
There was a non-significant reduction of the proportion of macrosomic and of LGA babies.

Conclusions

In our population the introduction of IADPSG screening criteria has increased the prevalence of GDM without having a statistically significant impact on pregnancy outcomes.
Literature
1.
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–53.CrossRef
2.
Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS, Group ACISiPWAT. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477–86.CrossRef
3.
Damm P. Future risk of diabetes in mother and child after gestational diabetes mellitus. Int J Gynaecol Obstet. 2009;104(Suppl 1):S25–6.CrossRef
4.
Casey BM, Lucas MJ, Mcintire DD, Leveno KJ. Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population. Obstet Gynecol. 1997;90(6):869–73.CrossRef
5.
Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002.CrossRef
6.
Catalano PM, McIntyre HD, Cruickshank JK, McCance DR, Dyer AR, Metzger BE, Lowe LP, Trimble ER, Coustan DR, Hadden DR, et al. The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care. 2012;35(4):780–6.CrossRef
7.
Feldman RK, Tieu RS, Yasumura L. Gestational diabetes screening: the International Association of the Diabetes and Pregnancy Study Groups Compared with Carpenter-Coustan Screening. Obstet Gynecol. 2016;127(1):10–7.CrossRef
8.
Gerome JM, Bucher LKM, Dogbey G. Effects of implementing International Association of Diabetes and Pregnancy Study Groups Gestational Diabetes Screening on pregnancy outcomes at a small community teaching hospital. Clin Diabetes. 2017;35(2):84–9.CrossRef
9.
Duran A, Sáenz S, Torrejón MJ, Bordiú E, Del Valle L, Galindo M, Perez N, Herraiz MA, Izquierdo N, Rubio MA, et al. Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnant women: the St. Carlos gestational diabetes study. Diabetes Care. 2014;37(9):2442–50.CrossRef
10.
Kong JM, Lim K, Thompson DM. Evaluation of the International Association of the Diabetes in Pregnancy Study Group new criteria: gestational diabetes project. Can J Diabetes. 2015;39(2):128–32.CrossRef
11.
Oriot P, Selvais P, Radikov J, Jacobs JL, Gilleman U, Loumaye R, Fernandez C. Assessing the incidence of gestational diabetes and neonatal outcomes using the IADPSG guidelines in comparison with the carpenter and Coustan criteria in a Belgian general hospital. Acta Clin Belg. 2014;69(1):8–11.CrossRef
12.
Metzger BE, Coustan DR. Summary and recommendations of the fourth international workshop-conference on gestational diabetes Mellitus. The organizing committee. Diabetes Care. 1998;21(Suppl 2):B161–7.PubMed
13.
Vanderijst J, Debieve F, Ducet F, Emonts P, et al. e dépistage et critères diagnostiques du diabète gestationnel. Propositions du GGOLFB. Rev Med Brux. 2012;33:97–104.PubMed
14.
15.
Clopper C, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934;26:404–13.CrossRef
16.
Mellitus ECotDaCoD. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(Suppl 1):S5–20.
17.
Benhalima K, Hanssens M, Devlieger R, Verhaeghe J, Mathieu C. Analysis of pregnancy outcomes using the new IADPSG recommendation compared with the carpenter and Coustan criteria in an area with a low prevalence of gestational diabetes. Int J Endocrinol. 2013;2013:248121.CrossRef
18.
Khalifeh A, Eckler R, Felder L, Saccone G, Caissutti C, Berghella V. One-step versus two-step diagnostic testing for gestational diabetes: a randomized controlled trial. J Matern Fetal Neonatal Med. 2018;13:1–6.
19.
Minsart AF, Lescrainier JP, Vokaer A. Selective versus universal screening for gestational diabetes mellitus: an evaluation of Naylor's model. Gynecol Obstet Investig. 2009;68(3):154–9.CrossRef
20.
Waters TP, Dyer AR, Scholtens DM, Dooley SL, Herer E, Lowe LP, Oats JJ, Persson B, Sacks DA, Metzger BE, et al. Maternal and neonatal morbidity for women who would be added to the diagnosis of GDM using IADPSG criteria: a secondary analysis of the hyperglycemia and adverse pregnancy outcome study. Diabetes Care. 2016;39(12):2204–10.CrossRef
21.
Lindqvist M, Persson M, Lindkvist M, Mogren I. No consensus on gestational diabetes mellitus screening regimes in Sweden: pregnancy outcomes in relation to different screening regimes 2011 to 2012, a cross-sectional study. BMC Pregnancy Childbirth. 2014;14:185.CrossRef
22.
Mayo K, Melamed N, Vandenberghe H, Berger H. The impact of adoption of the international association of diabetes in pregnancy study group criteria for the screening and diagnosis of gestational diabetes. Am J Obstet Gynecol. 2015;212(2):224.e221–9.CrossRef
23.
Organization WH: WHO | Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. WHO 2013.
24.
Weile LK, Kahn JG, Marseille E, Jensen DM, Damm P, Lohse N. Global cost-effectiveness of GDM screening and management: current knowledge and future needs. Best Pract Res Clin Obstet Gynaecol. 2015;29(2):206–24.CrossRef
25.
Parsons J, Sparrow K, Ismail K, Hunt K, Rogers H, Forbes A. Experiences of gestational diabetes and gestational diabetes care: a focus group and interview study. BMC Pregnancy Childbirth. 2018;18(1):25.CrossRef
Metadata
Title
Change in prevalence of gestational diabetes and obstetric complications when applying IADPSG screening criteria in a Belgian French speaking University Hospital. A retrospective cohort study
Authors
Elena Costa
Christine Kirckpartick
Colette Gerday
Aricia De Kempeneer
Sara Derisbourg
An Vercoutere
Sophie Haumont
Axelle Pintiaux
Caroline Daelemans
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Pregnancy and Childbirth / Issue 1/2019
Electronic ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-019-2406-4

Other articles of this Issue 1/2019

BMC Pregnancy and Childbirth 1/2019 Go to the issue

Research article

Maternal age and the risk of adverse pregnancy outcomes: a retrospective cohort study

Research article

Factors associated with the timing of the first prenatal ultrasound in Canada

Research article

Psychosocial and obstetric determinants of women signalling distress during Edinburgh Postnatal Depression Scale (EPDS) screening in Sydney, Australia

Research article

Association of first trimester maternal vitamin D, ferritin and hemoglobin level with third trimester fetal biometry: result from cohort study on vitamin D status and its impact during pregnancy and childhood in Indonesia

Research article

Knowledge and practice of immediate newborn care among midwives and nurses in public health facilities of Afar regional state, Northeast Ethiopia

Research article

Predisposing factors and neonatal outcomes for twin-twin transfusion syndrome cases developing transient donor hydrops after fetoscopic laser coagulation: a case control study